Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

385
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
385
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

185
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
185
Actuarial Approach01:20

Actuarial Approach

140
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
140
Life Tables01:22

Life Tables

216
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
216
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

202
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
202
Applications of Life Tables01:22

Applications of Life Tables

130
Life tables are versatile across various fields, providing a quantitative basis for analyzing mortality and survival rates. Whether used by demographers, actuaries, epidemiologists, or sociologists, life tables offer valuable insights into the dynamics of life and death, facilitating informed decisions in public health, insurance, conservation, and beyond. Their broad applicability highlights the interconnectedness of demographic data with practical outcomes in everyday life and strategic...
130

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fair Innings: An Empirical Test.

Health economics·2025
Same author

Monetary values of increasing life expectancy: Sensitivity to shifts of the survival curve.

Journal of risk and uncertainty·2023
Same author

Consistent valuation of a reduction in mortality risk using values per life, life year, and quality-adjusted life year.

Health economics·2023
Same author

Reappraising the public health benefits conferred by environmental policy: Considerations for an aging society.

Journal of the American Geriatrics Society·2022
Same author

Valuing COVID-19 Morbidity Risk Reductions.

Journal of benefit-cost analysis·2022
Same author

Prevention, treatment, and palliative care: The relative value of health improvements under alternative evaluation frameworks.

Journal of health economics·2022

Related Experiment Video

Updated: Sep 23, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Valuing non-marginal changes in mortality and morbidity risk.

Daniel Herrera-Araujo1, Christoph M Rheinberger2, James K Hammitt3

  • 1Université Paris-Dauphine, PSL Research University, LEDa (CGEMP) UMR CNRS, 8007, France.

Journal of Health Economics
|May 15, 2022
PubMed
Summary

This study introduces a new method to accurately value statistical lives (VSL) and cases (VSC) by using larger, more understandable risk reduction percentages. The approach corrects biases from these larger values, improving health and safety economic assessments.

Keywords:
Non-marginal risks reductionsScope sensitivityValue per statistical caseValue per statistical life

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Related Experiment Videos

Last Updated: Sep 23, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Area of Science:

  • Environmental Economics
  • Health Economics
  • Risk Assessment

Background:

  • Stated-preference studies often struggle with scope sensitivity when estimating willingness-to-pay (WTP) for small health risk reductions.
  • Small risk changes may not be perceived as meaningful by respondents, leading to inaccurate preference elicitation.
  • Existing methods may not fully capture public valuation of significant health improvements.

Purpose of the Study:

  • To propose a novel approach for estimating the value per statistical life (VSL) and value per statistical case (VSC).
  • To address the limitations of scope sensitivity in traditional stated-preference valuation methods.
  • To develop a de-biasing methodology for non-marginal risk reduction valuations.

Main Methods:

  • Developing a valuation framework based on larger, percent-change risk reductions.
  • Implementing a de-biasing technique to correct for biases introduced by non-marginal changes.
  • Utilizing simulated stated-preference data for a proof of concept.

Main Results:

  • The proposed method offers a way to estimate VSL and VSC using more comprehensible risk changes.
  • The de-biasing methodology effectively addresses known biases associated with non-marginal risk valuations.
  • Proof of concept demonstrates the feasibility and potential accuracy of the novel approach.

Conclusions:

  • The novel approach enhances the reliability of VSL and VSC estimates by using larger risk reductions.
  • This methodology provides a more robust tool for economic evaluation of health and safety policies.
  • Accurate valuation of health risks is crucial for effective public policy and resource allocation.